-
Conference Chairman Dr. Han Liang Discusses the Growth Path for Oncologic Surgeons and the Future of Surgical Oncology
From October 18 to 19, 2024, the CACA Gastric Cancer Integration Conference was held in Wuhan, bringing together multidisciplinary experts from both domestic and international fields to focus on the frontiers, standards, and progress in gastric cancer diagnosis and treatment. During the conference, Oncology Frontier had the opportunity to interview the conference chairman, Dr. Han…
-
Dr. Ying Cheng: New Approaches in Radiotherapy and Immunotherapy, Leading a New Era in the Treatment of Unresectable Lung Cancer
Radiotherapy combined with immunotherapy has become a significant focus in the treatment of unresectable lung cancer, but many key clinical questions remain unresolved. Establishing a consensus is crucial to guide standardized clinical practice. To address these needs, Academician Jinming Yu from Shandong Cancer Hospital, Dr. Ying Cheng from Jilin Cancer Hospital, and Dr. Lian’an Chen…
-
Prof. Zefei Jiang: Fostering SGBCC-CSCO Cooperation and Amplifying China’s Voice
From October 19-20, 2024, the first stop of the “St. Gallen Breast Cancer Conference China Tour” was held in Nanjing. This series of conferences is organized by the Breast Cancer Expert Committee of the Chinese Society of Clinical Oncology (CSCO), with support from the Beijing Xisike Clinical Oncology Research Foundation, the Beijing Kexin Medical Development…
-
Dr. Guangyu Liu: Redefining Beauty—Current Status and Future of Breast Reconstruction Techniques |16th Shanghai Breast Reconstruction Conference
Breast cancer is one of the most common malignancies among women, and while treatment methods continue to improve, maintaining patients’ quality of life while extending their survival remains a key focus in the medical community. With the emergence of oncoplastic surgery (OPS) and fat grafting techniques, the post-operative quality of life for breast cancer patients…
-
Dr. Jiong Wu: Enhancing Knowledge Exchange, Expanding Achievements in Breast Conservation and Reconstruction; Grasping New Trends in Neoadjuvant Immunotherapy| 16th Shanghai Breast Reconstruction Conference
From October 15-17, 2024, the 16th Shanghai Breast Reconstruction Conference and 5th Shanghai Breast Reconstruction Nursing Forum were successfully held, organized by the Chinese Anti-Cancer Association’s Breast Cancer Integration Committee and the Shanghai Anti-Cancer Association and hosted by Fudan University Shanghai Cancer Center. The conference focused on the status of breast conservation and reconstruction in…
-
SIBCS 2024 | Dr. Li Ma: Advances in Breast Surgery and Pathology Techniques and Prospects for the 2025 “Little Red Book” Updates
At the 2024 SIBCS conference, Dr. Li Ma from The Fourth Hospital of Hebei Medical University presented on the topic “Advances and Controversies in Breast Surgery and Pathology.” He addressed various hot topics, including: “Can axillary dissection be completely avoided in patients with 1–2 positive sentinel lymph nodes? Can axillary dissection be omitted after downstaging…
-
SIBCS 2024 | Dr. Qiang Liu: Major Clinical Trial Achievements in China’s Breast Cancer Treatment and Emerging Trends in Precision Therapy
n recent years, breast cancer treatment in China has undergone a remarkable transformation, from drug accessibility to treatment paradigms, aligning more closely with global standards. At the 2024 SIBCS conference, Dr. Qiang Liu from Sun Yat-sen Memorial Hospital, Sun Yat-sen University, delivered an insightful presentation on “Major Clinical Trial Achievements in China’s Breast Cancer Treatment,”…
-
Klebsiella pneumoniae: Leading Bacterial Killer in Clinical Settings – Dr. Chen Sheng Shares Advances at One Health Conference
1. Infectious Diseases Frontier: What global challenges does Klebsiella pneumoniae, as a significant drug-resistant pathogen, pose to public health? What are the primary difficulties in controlling its infections? Dr. Sheng…
Connecting Medical Expertise through Media